Small intestinal bacterial overgrowth (SIBO) is drastically higher in those with inflammatory bowel disease (IBD – Crohn’s and ulcerative colitis). After analyzing 11 studies, including over 1,100 IBD patients and 400 controls, researchers found that IBD patients are 9 times more likely to develop SIBO. Alimentary Pharmacology Therapeutics
→Takeaway: Why this incredible risk of developing SIBO in IBD patients? Scientists hypothesize that prior surgeries, gastric pH changes and compromised intestinal mucosal integrity, all common in IBD, could be to blame.
If you have IBD and/or think you may be suffering from SIBO, or if you are a practitioner who treats IBD and/or SIBO, check out Dr. Chutkan’s course, the Gutbliss Guide to SIBO for an incredible compilation of clinical information on testing, diagnosing, and treating SIBO.
